Island -
islandski -
LYFJASTOFNUN (Icelandic Medicines Agency)
doxycyklin eql pharma tafla 100 mg
eql pharma ab - doxycyclinum inn - tafla - 100 mg
Island -
islandski -
LYFJASTOFNUN (Icelandic Medicines Agency)
prednisolon eql pharma tafla 5 mg
eql pharma ab - prednisolonum inn - tafla - 5 mg
Island -
islandski -
LYFJASTOFNUN (Icelandic Medicines Agency)
risperidone teva gmbh stungulyfsstofn og leysir, forðadreifa 50 mg
teva gmbh - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 50 mg
Island -
islandski -
LYFJASTOFNUN (Icelandic Medicines Agency)
risperidone teva gmbh stungulyfsstofn og leysir, forðadreifa 25 mg
teva gmbh - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 25 mg
Island -
islandski -
LYFJASTOFNUN (Icelandic Medicines Agency)
risperidone teva gmbh stungulyfsstofn og leysir, forðadreifa 37,5 mg
teva gmbh - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 37,5 mg
Europska Unija -
islandski -
EMA (European Medicines Agency)
hyftor
plusultra pharma gmbh - sirolimus - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.
Island -
islandski -
LYFJASTOFNUN (Icelandic Medicines Agency)
clindamycin eql pharma hart hylki 150 mg
eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 150 mg
Island -
islandski -
LYFJASTOFNUN (Icelandic Medicines Agency)
clindamycin eql pharma hart hylki 300 mg
eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 300 mg
Island -
islandski -
LYFJASTOFNUN (Icelandic Medicines Agency)
protaminsulphat leo pharma stungulyf, lausn 10 mg/ml
leo pharma a/s* - protamini sulfas inn - stungulyf, lausn - 10 mg/ml
Island -
islandski -
LYFJASTOFNUN (Icelandic Medicines Agency)
túfen saft 13,33 mg/ml
laboratoria qualiphar - guaifenesinum inn - saft - 13,33 mg/ml